512101 — Triochem Products Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Triochem Products, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.81 | 17.6 | -11.7 | -13.3 | -2.46 |
| Depreciation | |||||
| Non-Cash Items | 0.03 | -2.94 | -8.1 | -4.77 | -3.93 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 107 | 18.8 | 2.98 | -20.4 | 7.63 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 103 | 34.7 | -15.8 | -37.6 | 2.01 |
| Capital Expenditures | -0.237 | -0.268 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.253 | 1.86 | -92.7 | 33.4 | 1.68 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.016 | 1.59 | -92.7 | 33.4 | 1.68 |
| Financing Cash Flow Items | -1.09 | -0.152 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -26.1 | -0.152 | 0 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 76.4 | 36.1 | -109 | -4.21 | 3.69 |